NEURO2024

Presentation information

Print

Oral

[1O01e] Neurological diseases 1

Wed. Jul 24, 2024 5:00 PM - 6:00 PM Room 1 (Main Hall)

Chairperson: Koji Yamanaka (Nagoya University, Reserach Institute of Environmental Medicine), Atsushi Sugie (Brain Research Institute, Niigata University)

[1O01e-02] Exploring the Therapeutic Potential of LIMK1/2 Inhibitors in Amyotrophic Lateral Sclerosis: Targeting Actin Dynamics via Cofilin Modulation

*Cyril Jones Jagaraj1, Angela Laird1, Julie Atkin1,2 (1. MND Research Centre, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, 2. La Trobe Institute for Molecular Science, La Trobe University)

Keywords:ALS, Actin dysregulation , novel therapy, mouse pre-clinical studies

Abstract password authentication.
A password is required to view the full text of the abstract. Please enter the following password.

PW: Neuro2024

Password